Patents by Inventor Yong Baik
Yong Baik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11925065Abstract: A display panel includes a switching transistor and a light-emitting transistor. The switching transistor includes a first gate electrode, a first source electrode, a first active layer, and a first drain electrode. The light-emitting transistor includes a second gate electrode, a second source electrode, a second active layer, a light-emitting layer, and a second drain electrode. The second gate electrode is the first drain electrode of the switching transistor. The switching transistor and the light-emitting transistor may be on a substrate. The switching transistor, the second source electrode, the second active layer, the light-emitting layer, and the second drain electrode are stacked in a direction perpendicular to the surface of the substrate.Type: GrantFiled: February 25, 2022Date of Patent: March 5, 2024Assignee: Samsung Electronics Co., Ltd.Inventors: Ajeong Choi, Yong Uk Lee, Chul Baik
-
Patent number: 11154542Abstract: The present invention relates to a nail lacquer composition containing at least one antifungal agent as a pharmacologically active ingredient. The present invention has an excellent penetrating effect of a drug in skin areas where the drug is applied because of needing treatment and, specifically, in fingernails by containing a polymer material which forms a specific film, and a penetration enhance, is convenient for management after locally applying the drug to a treatment site, and has excellent storage stability of the drug.Type: GrantFiled: March 9, 2016Date of Patent: October 26, 2021Assignee: GENUONE SCIENCES INC.Inventors: Nam-hyang Kim, Yong-baik Cho, Sang-young Jeong, Byoung-chan Bae, Jae-seong Lee, Ji-won Lee, Hong-koo Cho
-
Patent number: 11123388Abstract: Provided is a pharmaceutical composition for preventing or treating inflammatory bowel disease (IBD) comprising a mixed extract of at least two of Aucklandia lappa Decne, Terminalia chebula Retzius, and Zingiber officinale Rosc. as an active ingredient and a method thereof, and more specifically, to a pharmaceutical composition having an inhibitory effect on monocyte adhesion in intestinal epithelial cells, an effect of inhibiting the production of inflammatory cytokines, an effect of ameliorating colitis in an animal model of dextran sodium sulfate (DSS)-induced colitis, and an effect of ameliorating Crohn's disease in an animal model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced Crohn's disease.Type: GrantFiled: November 4, 2016Date of Patent: September 21, 2021Assignee: GENUONE SCIENCES INC.Inventors: Yong-baik Cho, Seul-ki Kim, Sang-Back Kim, Jae-hyuck Shin, Young-ran Um, So-youn Mok, Ju-ri Jung, Soon-min Lim, Chae Shin Seo, Hong Koo Cho, Bon Am Koo, Hyo Jin Jeon, Han-Seok Choi, Ye Jin Kim
-
Publication number: 20210077596Abstract: The present invention relates to a novel botulinum toxin composition having increased safety and reduced side effects. The composition of the present invention is prepared by adding zinc to a botulinum toxin. The composition, of the present invention, containing a botulinum toxin and zinc, has been confirmed to increase the survival rate of rats and have a greatly prolonged toxin efficacy duration when intramuscularly administered to the rats.Type: ApplicationFiled: July 24, 2018Publication date: March 18, 2021Inventors: Daeik KIM, Yong-Baik CHO, Inra SEO
-
Publication number: 20180303888Abstract: Provided is a pharmaceutical composition for preventing or treating inflammatory bowel disease (IBD) comprising a mixed extract of at least two of Aucklandia lappa Decne, Terminalia chebula Retzius, and Zingiber officinale Rosc. as an active ingredient and a method thereof, and more specifically, to a pharmaceutical composition having an inhibitory effect on monocyte adhesion in intestinal epithelial cells, an effect of inhibiting the production of inflammatory cytokines, an effect of ameliorating colitis in an animal model of dextran sodium sulfate (DSS)-induced colitis, and an effect of ameliorating Crohn's disease in an animal model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced Crohn's disease.Type: ApplicationFiled: November 4, 2016Publication date: October 25, 2018Inventors: Yong-baik CHO, Seul-ki KIM, Sang-Back KIM, Jae-hyuck SHIN, Young-ran UM, So-youn MOK, Ju-ri JUNG, Soon-min LIM, Chae Shin SEO, Hong Koo CHO, Bon Am KOO, Hyo Jin JEON, Han-Seok CHOI, Ye Jin KIM
-
Publication number: 20180104227Abstract: The present invention relates to a nail lacquer composition containing at least one antifungal agent as a pharmacologically active ingredient. The present invention has an excellent penetrating effect of a drug in skin areas where the drug is applied because of needing treatment and, specifically, in fingernails by containing a polymer material which forms a specific film, and a penetration enhance, is convenient for management after locally applying the drug to a treatment site, and has excellent storage stability of the drug.Type: ApplicationFiled: March 9, 2016Publication date: April 19, 2018Inventors: Nam-hyang KIM, Yong-baik CHO, Sang-young JEONG, Byoung-chan BAE, Jae-seong LEE, Ji-won LEE, Hong-koo CHO
-
Patent number: 9833487Abstract: In some embodiments, a composition for the treatment and inhibition or prevention of arthritic diseases includes an extract of mixed herbs, the mixed herbs including an active ingredient with Lonicera japonica THUNB and Anemarrhena asphodeloides BUNGE.Type: GrantFiled: February 19, 2009Date of Patent: December 5, 2017Assignee: University-Industry Cooperation Group of Kyung Hee UniversityInventors: Dong-Suk Park, Myung Chul Yoo, Do-Young Choi, Hyung In Yang, Yong-Hyeon Baek, Jeong-Eun Huh, Kyoung Soo Kim, Yong-Baik Cho, In Ho Jung, Jong Hyun Hur, Jae Dong Lee
-
Patent number: 9180153Abstract: The present invention relates to an extract isolated from Sophorae Radix useful for prevention and treatment of respiratory diseases. More specifically, the present invention relates to a pharmaceutical drug comprising the Sophorae Radix extract having excellent effects of inhibiting airway contraction, respiratory infections, 5-lipoxygenase activity, phosphodiesterase 4 activity, airway hyper-responsiveness and airway remodeling; antagonistic activity against leukotriene D4; and an antitussive effect, thus being useful for prevention and treatment of respiratory diseases such as asthma, acute or chronic bronchitis, allergic rhinitis, acute upper respiratory infections and acute lower respiratory infections, and the like.Type: GrantFiled: May 12, 2010Date of Patent: November 10, 2015Assignee: SK Chemicals Co., Ltd.Inventors: Chang-Kyun Han, Kiwon Joung, Hunseung Yoo, Yong-Baik Cho, Keun Ho Ryu, Hye Yeon Baek, Taek-Soo Kim, In Ho Jung, Wie-Jong Kwak
-
Patent number: 8652537Abstract: The present invention relates to a herbal drug composition for cartilage protection comprising plant extracts of Clematis Radix, Trichosanthis Radix, and Prunellae Spica and an optimal content of rosmarinic acid to: (i) alleviate pains; (ii) inhibit the acute/chronic inflammation, platelet/whole blood aggregation, immunocyte (B-lymphcyte and T-lymphcyte) proliferation, inflammation-inducing enzyme activities, and enzyme activities associated with degradation of joint tissue; (iii) scavenge activity of toxic active oxygen radicals; and (iv) further provide excellent cartilage protection activity to be effectively used as an anti-inflammatory agent with analgesic effects, blood circulation enhancer, arthritis therapeutic agent and cartilage protective.Type: GrantFiled: February 21, 2012Date of Patent: February 18, 2014Assignee: SK Chemicals Co., Ltd.Inventors: Chang-Kyun Han, Wie-Jong Kwak, Ki Won Joung, Hun Seung Yoo, Do Seung Kum, Yong-Baik Cho, Keun Ho Ryu, Hae In Rhee, Taek Su Kim, In Ho Jung, So Yoon Lee, Jung Bum Yi, Joo Hyon Kim, Key An Um
-
Publication number: 20140030368Abstract: The present invention relates to a composition for preventing or treating a respiratory disease containing an active ingredient in the form of a mixed herbal extract of Cnidii Rhizoma and Polygoni cuspidati Radix, and relates to a production method therefor. The mixed herbal extract of Cnidii Rhizoma and Polygoni cuspidati Radix has an outstanding 5-lipoxygenase suppressing activity, airway constriction suppressing activity, airway inflammation suppressing action, ear-swelling anti-inflammatory effect and antitussive and phlegm-loosening action, and has been confirmed to be useful in preventing or treating respiratory diseases including asthma, chronic obstructive pulmonary disease, acute and chronic bronchitis, allergic rhinitis, cough, expectoration, acute lower respiratory infections (bronchitis and bronchiolitis), and acute upper respiratory infections such an pharyngitis, tonsillitis and laryngitis.Type: ApplicationFiled: January 30, 2012Publication date: January 30, 2014Applicant: WHANIN PHARMACEUTICAL CO., LTD.Inventors: Yong Baik Cho, Moon Kyu Kang, In Ho Jung, Jong Hyun Hur, Soon Han Kim, Kyoung Chul Jung, Je Young Lee, Seul Ki Kim, Jee Young Lee, Byung Chul Yu, Min-Kyong Hyon
-
Publication number: 20120148693Abstract: The present invention relates to a herbal drug composition for cartilage protection comprising plant extracts of Clematis Radix, Trichosanthis Radix, and Prunellae Spica and an optimal content of rosmarinic acid to: (i) alleviate pains; (ii) inhibit the acute/chronic inflammation, platelet/whole blood aggregation, immunocyte (B-lymphcyte and T-lymphcyte) proliferation, inflammation-inducing enzyme activities, and enzyme activities associated with degradation of joint tissue; (iii) scavenge activity of toxic active oxygen radicals; and (iv) further provide excellent cartilage protection activity to be effectively used as an anti-inflammatory agent with analgesic effects, blood circulation enhancer, arthritis therapeutic agent and cartilage protective.Type: ApplicationFiled: February 21, 2012Publication date: June 14, 2012Inventors: Chang-Kyun HAN, Wie-Jong KWAK, Ki Won JOUNG, Hun Seung YOO, Do Seung KUM, Yong-Baik CHO, Keun Ho RYU, Hae In RHEE, Taek Su KIM, In Ho JUNG, So Yoon LEE, Jung Bum YI, Joo Hyon KIM, Key An UM
-
Publication number: 20120141725Abstract: A floor mat including a carpet portion, one or more hook-and-loop fastener portions, an anti-slip portion, and an edge portion is provided. The carpet portion is disposed on a top surface. The one or more hook-and-loop fastener portions are disposed on a bottom surface, each of which being corresponds to a counter fastener portion installed on a floor. The anti-slip portion is disposed on the bottom surface, comprising a plurality of bumps protruding downward from the bottom surface. The edge portion surrounds and secures the top and bottom surface. The bumps are disposed in a predetermined density and pattern. The carpet portion may comprise durable fabric.Type: ApplicationFiled: December 7, 2010Publication date: June 7, 2012Inventors: Yong Baik JUNG, Sung Jin BYUN
-
Patent number: 8158168Abstract: The present invention relates to a Momordicae semen extract effective in the prevention and treatment of gastritis or gastric ulcer and momordica saponin I isolated therefrom. The Momordicae semen extract and the momordica saponin I isolated therefrom is effective in the prevention and treatment of gastritis or gastric ulcer since they prevent the damage of the gastric mucosa caused by alcohols and inhibit the secretion of gastric acid.Type: GrantFiled: August 16, 2010Date of Patent: April 17, 2012Assignee: SK Chemicals Co., Ltd.Inventors: Bong Cheol Kim, Joo Hyon Kim, Se Jun Yun, Eun Jung Noh, Gi Uk Jang, Chang-Kyun Han, Yong-Baik Cho, Wie-Jong Kwak
-
Patent number: 8048912Abstract: The present invention relates to a novel benzopyran derivative having goodantagonistic activity on TGF-? receptor which can be effectively used as a prophylactic and therapeutic agent for liver disease as well as several fibroplasiadiseases such as hepatic fibrosis, liver cirrhosis, pulmonary fibrosis, dermatosclerosis, glomerular fibrosis and the like; and a pharmaceutical use thereof.Type: GrantFiled: June 15, 2005Date of Patent: November 1, 2011Assignees: SK Chemicals Co., Ltd., Korea Research Institute of Chemical TechnologyInventors: Young-Dae Gong, Jin-Soo Seo, Moon-Kook Jeon, Wie-Jong Kwak, Yong-Baik Cho, Nam Kyu Lee, Eun Ju Lee, Jung Bum Lee, Jun Won Lee, Sukho Lee, Mi-Sook Dong, Jeong-Ran Kim
-
Publication number: 20110003018Abstract: In some embodiments, a composition for the treatment and inhibition or prevention of arthritic diseases includes an extract of mixed herbs, the mixed herbs including an active ingredient with Lonicera japonica THUNB and Anemarrhena asphodeloides BUNGE.Type: ApplicationFiled: February 19, 2009Publication date: January 6, 2011Inventors: Dong-Suk Park, Myung Chul Yoo, Do-Young Choi, Hyung In Yang, Yong-Hyeon Baek, Jeong-Eun Huh, Kyoung Soo Kim, Yong-Baik Cho, In Ho Jung, Jong Hyun Hur, Jae Dong Lee
-
Publication number: 20100310687Abstract: The present invention relates to a Momordicae semen extract effective in the prevention and treatment of gastritis or gastric ulcer and momordica saponin I isolated therefrom. The Momordicae semen extract and the momordica saponin I isolated therefrom is effective in the prevention and treatment of gastritis or gastric ulcer since they prevent the damage of the gastric mucosa caused by alcohols and inhibit the secretion of gastric acid.Type: ApplicationFiled: August 16, 2010Publication date: December 9, 2010Applicant: SK Chemicals Co., Ltd.Inventors: Bong Cheol KIM, Joo Hyon Kim, Se Jun Yun, Eun Jung Noh, Gi Uk Jang, Chang-Kyun Han, Yong-Baik Cho, Wie-Jong Kwak
-
Publication number: 20100221371Abstract: The present invention relates to an extract isolated from Sophorae Radix useful for prevention and treatment of respiratory diseases. More specifically, the present invention relates to a pharmaceutical drug comprising the Sophorae Radix extract having excellent effects of inhibiting airway contraction, respiratory infections, 5-lipoxygenase activity, phosphodiesterase 4 activity, airway hyper-responsiveness and airway remodeling; antagonistic activity against leukotriene D4; and an antitussive effect, thus being useful for prevention and treatment of respiratory diseases such as asthma, acute or chronic bronchitis, allergic rhinitis, acute upper respiratory infections and acute lower respiratory infections, and the like.Type: ApplicationFiled: May 12, 2010Publication date: September 2, 2010Inventors: Chang-Kyun HAN, Kiwon Joung, Hunseung Yoo, Yong-Baik Cho, Keun Ho Ryu, Hye Yeon Baek, Taek-Soo Kim, In Ho Jung, Wie-Jong Kwak
-
Patent number: 7601736Abstract: The invention relates to novel pyridine derivatives having an inhibitory effect on production of cytokines, which are involved in inflammatory responses, thus suggesting its usefulness as therapeutic agents for treating diseases related to inflammation, immune, chronic inflammation as well as an agent having an anti-inflammatory and analgesic effect. Further, this invention relates to a method of manufacturing the same and a pharmaceutical composition containing the same.Type: GrantFiled: December 30, 2004Date of Patent: October 13, 2009Assignee: SK Chemicals Co., Ltd.Inventors: Hyung Ook Kim, Nam Kyu Lee, Joo Hyon Kim, Hae In Rhee, Yong-Baik Cho, Je Ho Ryu, Nam Ho Kim, Keun Ho Ryu, Jung Bum Yi, Jae Yoon Jung
-
Patent number: D968210Type: GrantFiled: May 12, 2021Date of Patent: November 1, 2022Assignee: BO DO KO USA, INC.Inventor: Yong Baik Jung
-
Patent number: D987498Type: GrantFiled: June 9, 2021Date of Patent: May 30, 2023Assignee: MOTORBOX, INC.Inventor: Yong Baik Jung